Anti-CYP2A13 antibody
Specifications
| Product Cat#: | AB-06-1247 |
| Product type: | Primary antibody |
| Antigen: | CYP2A13 |
| Immunogen: | KLH conjugated synthetic peptide derived from human CYP2A13 301-400/494 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:500-1:2000) |
| Reactivity: | Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 10mM Tris-HCl buffer (pH7.4), 1% BSA, 50% glycerol, 0.03% Proclin300. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | CP2AD_HUMAN |
| CPAD | |
| CYP2A | |
| CYP2A13 | |
| CYPIIA13 | |
| Cytochrome P450 2A13 |
Show More
Target information
Exhibits a coumarin 7-hydroxylase activity. Active in the metabolic activation of hexamethylphosphoramide, N,N-dimethylaniline, 2′-methoxyacetophenone, N-nitrosomethylphenylamine, and the tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Possesses phenacetin O-deethylation activity.
Provider
Erpantech Laboratory